Global Oral Contrast Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Contrast Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Contrast Agent report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Contrast Agent market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cardiovascular Disorders and Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Contrast Agent industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Contrast Agent key manufacturers include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India) and Spago Nanomedicine (Sweden), etc. GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany) are top 3 players and held % sales share in total in 2022.
Oral Contrast Agent can be divided into Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media, etc. Barium-based Contrast Media is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Contrast Agent is widely used in various fields, such as Cardiovascular Disorders, Cancer, Gastrointestinal Disorders and Musculoskeletal Disorders, etc. Cardiovascular Disorders provides greatest supports to the Oral Contrast Agent industry development. In 2022, global % sales of Oral Contrast Agent went into Cardiovascular Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Contrast Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Contrast Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Contrast Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Contrast Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Contrast Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Contrast Agent introduction, etc. Oral Contrast Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Contrast Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Oral Contrast Agent industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Contrast Agent key manufacturers include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India) and Spago Nanomedicine (Sweden), etc. GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany) are top 3 players and held % sales share in total in 2022.
Oral Contrast Agent can be divided into Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media, etc. Barium-based Contrast Media is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Contrast Agent is widely used in various fields, such as Cardiovascular Disorders, Cancer, Gastrointestinal Disorders and Musculoskeletal Disorders, etc. Cardiovascular Disorders provides greatest supports to the Oral Contrast Agent industry development. In 2022, global % sales of Oral Contrast Agent went into Cardiovascular Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Contrast Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segment by Application
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Contrast Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Contrast Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Contrast Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Contrast Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Contrast Agent introduction, etc. Oral Contrast Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Contrast Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.